The value of aggressive therapy in the hypertensive patient with azotemia.
D000284:Administration, Oral; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001158:Arteries; D001794:Blood Pressure; D001806:Blood Urea Nitrogen; D003404:Creatinine / Q000097:blood; D003981:Diazoxide / Q000008:administration & dosage* / Q000494:pharmacology / Q000627:therapeutic use*; D004357:Drug Synergism; D005260:Female; D005665:Furosemide / Q000008:administration & dosage* / Q000627:therapeutic use*; D006333:Heart Failure / Q000150:complications / Q000188:drug therapy; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009584:Nitrogen / Q000097:blood; D010211:Papilledema / Q000150:complications / Q000188:drug therapy; D014511:Uremia / Q000188:drug therapy* / Q000209:etiology; D014882:Water-Electrolyte Balance
D000959:Antihypertensive Agents; D005665:Furosemide; D003404:Creatinine; D009584:Nitrogen; D003981:Diazoxide